Amongst the many ploys used by microbial pathogens to interfere with host immune responses is the production of proteins with the properties of superantigens. These properties enable superantigens to interact with conserved variable region framework subdomains of the antigen receptors of lymphocytes rather than the complementarity determining region involved in the binding of conventional antigens. To understand how a B cell superantigen affects the host immune system, we infused protein A of Staphylococcus aureus (SpA) and followed the fate of peripheral B cells expressing B cell receptors (BCRs) with VH regions capable of binding SpA. Within hours, a sequence of events was initiated in SpA-binding splenic B cells, with rapid down-regulation of BCRs and coreceptors, CD19 and CD21, the induction of an activation phenotype, and limited rounds of proliferation. Apoptosis followed through a process heralded by the dissipation of mitochondrial membrane potential, the induction of the caspase pathway, and DNA fragmentation. After exposure, B cell apoptotic bodies were deposited in the spleen, lymph nodes, and Peyer's patches. Although in vivo apoptosis did not require the Fas death receptor, B cells were protected by interleukin (IL)-4 or CD40L, or overexpression of Bcl-2. These studies define a pathway for BCR-mediated programmed cell death that is VH region targeted by a superantigen.
Skip Nav Destination
Article navigation
5 May 2003
Article|
April 28 2003
Death by a B Cell Superantigen : In Vivo VH-targeted Apoptotic Supraclonal B Cell Deletion by a Staphylococcal Toxin
Carl S. Goodyear,
Carl S. Goodyear
Rheumatic Disease Core Center, Department of Medicine, University of California San Diego, La Jolla, CA 92093
Search for other works by this author on:
Gregg J. Silverman
Gregg J. Silverman
Rheumatic Disease Core Center, Department of Medicine, University of California San Diego, La Jolla, CA 92093
Search for other works by this author on:
Carl S. Goodyear
Rheumatic Disease Core Center, Department of Medicine, University of California San Diego, La Jolla, CA 92093
Gregg J. Silverman
Rheumatic Disease Core Center, Department of Medicine, University of California San Diego, La Jolla, CA 92093
Address correspondence to Gregg Silverman, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093. Phone: 858-534-5439; Fax: 858-534-5399; E-mail: [email protected]
*
Abbreviations used in this paper: AICD, activation-induced cell death; BCR, B cell receptor; CFSE, carboxyfluorescein diacetate succinimidylester; ΔΨm, mitochondrial transmembrane potential; PI, propidium iodide; SpA, protein A of Staphylococcus aureus; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling; Z-VAD, Z-Val-Ala-Asp(OMe)-fluoromethyl ketone.
Received:
April 08 2002
Revision Received:
February 14 2003
Accepted:
March 10 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 197 (9): 1125–1139.
Article history
Received:
April 08 2002
Revision Received:
February 14 2003
Accepted:
March 10 2003
Citation
Carl S. Goodyear, Gregg J. Silverman; Death by a B Cell Superantigen : In Vivo VH-targeted Apoptotic Supraclonal B Cell Deletion by a Staphylococcal Toxin . J Exp Med 5 May 2003; 197 (9): 1125–1139. doi: https://doi.org/10.1084/jem.20020552
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement